Interaction Analysis of the Spike Protein of Delta and Omicron Variants of SARS-CoV-2 with hACE2 and Eight Monoclonal Antibodies Using the Fragment Molecular Orbital Method | Journal of Chemical Information and Modeling
Rapid assessment of SARS-CoV-2–evolved variants using virus-like particles | Science
Frontiers | Nanobodies Protecting From Lethal SARS-CoV-2 Infection Target Receptor Binding Epitopes Preserved in Virus Variants Other Than Omicron
Frontiers | Heteromerization Modulates mu Opioid Receptor Functional Properties in vivo
Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies | Cell Discovery
Novel Mixed NOP/Opioid Receptor Peptide Agonists | Journal of Medicinal Chemistry
IJMS | Free Full-Text | Syndecan-4 Is a Key Facilitator of the SARS-CoV-2 Delta Variant’s Superior Transmission
Identification and differential usage of a host metalloproteinase entry pathway by SARS-CoV-2 Delta and Omicron - ScienceDirect
Singular Interface Dynamics of the SARS-CoV-2 Delta Variant Explained with Contact Perturbation Analysis | Journal of Chemical Information and Modeling
Frontiers | Regulator of G-Protein Signaling (RGS) Protein Modulation of Opioid Receptor Signaling as a Potential Target for Pain Management
Differential Interactions between Human ACE2 and Spike RBD of SARS-CoV-2 Variants of Concern | Journal of Chemical Theory and Computation
Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum | NEJM
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
A Universal DNA Aptamer that Recognizes Spike Proteins of Diverse SARS‐CoV‐2 Variants of Concern - Zhang - 2022 - Chemistry – A European Journal - Wiley Online Library
The G protein-first activation mechanism of opioid receptors by Gi protein and agonists | QRB Discovery | Cambridge Core
SARS-CoV-2 Beta and Delta variants trigger Fc effector function with increased cross-reactivity - ScienceDirect
Viruses | Free Full-Text | Genomic Epidemiology of the SARS-CoV-2 Epidemic in Cyprus from November 2020 to October 2021: The Passage of Waves of Alpha and Delta Variants of Concern
Frontiers | The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape
Deep learning guided optimization of human antibody against SARS-CoV-2 variants with broad neutralization | PNAS
Functional expression of opioid receptors and other human GPCRs in yeast engineered to produce human sterols | Nature Communications
The antigenicity of SARS-CoV-2 Delta variants aggregated 10 high-frequency mutations in RBD has not changed sufficiently to replace the current vaccine strain | Signal Transduction and Targeted Therapy
Kappa Delta Sorority - Gamma Kappa Chapter at UL Lafayette
Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists | Science Advances
IJERPH | Free Full-Text | Shorter Incubation Period among Unvaccinated Delta Variant Coronavirus Disease 2019 Patients in Japan
Frontiers | Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies
Molecules | Free Full-Text | Severe Acute Respiratory Syndrome Coronavirus-2 Inactivation Activity of the Polyphenol-Rich Tea Leaf Extract with Concentrated Theaflavins and Other Virucidal Catechins
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion | Nature
Vaccines | Free Full-Text | Vaccine versus Variants (3Vs): Are the COVID-19 Vaccines Effective against the Variants? A Systematic Review
